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Abstract
Background: The pathogenesis of enterohemorrhagic Escherichia coli (EHEC) O157:H7 infection is attributed to virulence
factors encoded on multiple pathogenicity islands. Previous studies have shown that EHEC O157:H7 modulates host cell
signal transduction cascades, independent of toxins and rearrangement of the cytoskeleton. However, the virulence factors
and mechanisms responsible for EHEC-mediated subversion of signal transduction remain to be determined. Therefore, the
purpose of this study was to first identify differentially regulated genes in response to EHEC O157:H7 grown in the presence
of epithelial cells, compared to growth in the absence of epithelial cells (that is, growth in minimal essential tissue culture
medium alone, minimal essential tissue culture medium in the presence of 5% CO2, and Penassay broth alone) and, second,
to identify EHEC virulence factors responsible for pathogen modulation of host cell signal transduction.
Methodology/Principal Findings: Overnight cultures of EHEC O157:H7 were incubated for 6 hr at 37uC in the presence or
absence of confluent epithelial (HEp-2) cells. Total RNA was then extracted and used for microarray analyses (Affymetrix E.
coli Genome 2.0 gene chips). Relative to bacteria grown in each of the other conditions, EHEC O157:H7 cultured in the
presence of cultured epithelial cells displayed a distinct gene-expression profile. A 2.0-fold increase in the expression of 71
genes and a 2.0-fold decrease in expression of 60 other genes were identified in EHEC O157:H7 grown in the presence of
epithelial cells, compared to bacteria grown in media alone.
Conclusion/Significance: Microarray analyses and gene deletion identified a protease on O-island 50, gene Z1787, as a
potential virulence factor responsible for mediating EHEC inhibition of the interferon (IFN)-c-Jak1,2-STAT-1 signal
transduction cascade. Up-regulated genes provide novel targets for use in developing strategies to interrupt the infectious
process.
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Introduction
Enterohemorrhagic Escherichia coli (EHEC; also variously
referred to as Verocytotoxin producing E. coli, VTEC and Shiga
toxin producing E. coli, STEC), serotype O157:H7 is a serious
human enteric pathogen, as evidenced by an outbreak across
North America due to the ingestion of contaminated spinach [1] .
Symptoms of EHEC infection range from mild diarrhea to
hemorrhagic colitis and, in the most severe cases, the hemolytic
uremic syndrome [2]. EHEC O157:H7 virulence factors include
phage-encoded Shiga toxins and intimate bacterial adhesion,
described as attaching-effacing lesions [3]. Formation of attaching-
effacing lesions is caused by effector proteins and a type three
secretion system, which are encoded on a locus of enterocyte
effacement (LEE) pathogenicity island [4]. EHEC O157:H7
disease pathogenesis also is related to microbial modulation of
eukaryotic signal transduction cascades. For instance, previous
studies showed that EHEC disrupts host innate immune signaling
responses, including the IFNc-Jak1,2-STAT-1 signal transduction
cascade [5–7]. EHEC subversion of STAT-1 activation by IFNc
involves a prokaryotic factor that requires bacterial contact with
the host epithelial cell.
The complete genome sequences of two EHEC O157:H7
strains have been reported previously [8,9]. E. coli O157:H7 strain
EDL933 contains 1.34 Mb of genomic information that is absent
in non-pathogenic E. coli, strain K-12 [9]. This extra DNA is
organized into 177 putative genomic islands, ranging in size from
less than 10 to greater than 100 kilobases [8]. Global gene
expression profiling is a strategy that can be used to better
understand mechanisms underlying host pathogen interactions in
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e4889response to infection (reviewed in: [10]). Studies describing gene
expression profiling of E. coli are limited having focused on either
phylogenetic analyses [11–14] or changes in gene expression in
response to varying environmental growth conditions [15–20]. By
contrast, only a few studies have delineated E. coli gene expression
in the context of infection models. One recent study performed
gene expression profiling of two urinary tract E. coli strains,
originally isolated from subjects with asymptomatic bacteriuria
[21]. Only one previous study described a differential gene
expression pattern of EHEC O157:H7 during pathogen growth
with erythrocytes, relative to growth in tissue culture medium [22].
Consequently, gene expression studies of EHEC O157:H7 in the
context of infected epithelia are lacking. In addition, despite
extensive research on the effects of EHEC on host cell signaling,
relatively few bacterial factors responsible for pathogenic effects
have been identified [23].
Therefore, the purpose of this study was to perform comparative
gene expression analysis of EHEC O157:H7 grown in the presence
of cultured epithelial cells, relative to growth in the absence of
epithelial cells. In addition, gene expression analysis was performed
to identify virulence factors involved in EHEC disruption of the
IFNc-Jak1,2-STAT-1 signal transduction cascade.
Results
Relatedness of gene-expression profiles of EHEC
O157:H7, strain CL56 cultured under four different
growth conditions
Microarray analysis was employed to identify global gene
expression changes of EHEC O157:H7 grown in the presence of
epithelial cells, relative to the same organism grown in the absence
of epithelial cells (Penassay broth, minimal essential tissue culture
medium or minimal essential tissue culture medium in 5% CO2).
Principle Components Analysis (PCA), using the Partek Genomics
Suite, was performed to confirm the relatedness of data sets. This
method of cluster analysis also was used to identify outliers in the
data set. Data from all 19 microarray gene chips generated a
correlation value (i.e. PCA value) of 68.9% with two distinct
outliers. Removal of these outliers resulted in a correlation value of
68.4% for the remaining 17 gene chips, which were then used for
all subsequent data analyses (Supplemental Figure S1).
Individual principle components analysis for each group of gene
chips, representing EHEC growth under all four conditions each
revealed correlation values of 100%.
Gene expression pattern of EHEC O157:H7 housekeeping
genes under different growth conditions
Housekeeping genes provided internal controls, which were
used as a measure of mRNA expression levels irrespective of
growth condition [24]. The expression patterns of five E. coli
housekeeping genes were determined including, arcA, gapA, mdh,
rfbA, and rpoS [25] during EHEC O157:H7 growth in the presence
or absence of epithelial cells. The signal intensities of these select
housekeeping genes, as determined by microarray analysis, are
shown in Figure 1, Panel A. Signal intensities of these
housekeeping genes were comparable for samples of EHEC
O157:H7 under each of the four different growth conditions.
As shown in Figure 1, Panel B, qRT-PCR of the
housekeeping genes, arcA, gapA, mdh, rfbA, and rpoS also showed
comparable levels of transcript expression (n=3, p.0.05,
ANOVA), irrespective of EHEC growth condition. Collectively,
these results validate the microarray data and allowed for
subsequent data analysis of expression patterns for selected
potential virulence genes.
Differentially regulated genes during EHEC O157:H7
growth in the presence of epithelial cells, relative to the
absence of epithelial cells
Differentially regulated genes in response to EHEC O157:H7
growth in the presence of epithelial cells relative to the absence of
Figure 1. Relative expression of EHEC O157:H7, strain CL56
housekeeping genes in response to different growth condi-
tions. [Panel A] Signal intensities of housekeeping genes (arcA, gapA,
mdh, rfbA and rpoS) from microarray chips in response to EHEC O157:H7
grown under four different conditions. All housekeeping genes showed
similarlevelsof expression, irrespectiveofthebacterialgrowthcondition.
Data are presented as means6SEM. [Panel B] qRT-PCR of the same
housekeepinggenesconfirms comparable levels of transcript expression,
irrespective of EHEC O157:H7 growth condition. Data points from
triplicates of EHEC O157:H7 grown in contact with epithelial cells,
microbial growth in minimal essential medium (+/25% CO2)w e r e
extrapolated from a standard curve generated for each primer pair using
samples of the same bacterial strain grown in Penassay broth alone. As
described in the Experimental procedures, data analysis was performed
using the 7500 Sequence Detection System Software package (Applied
Biosystems). Blackbars representEHECO157:H7grownin the presence
of epithelial cells; grey bars: pathogen grown in minimal essential
medium in atmospheric conditions or in 5% CO2 (stripped bars). EHEC
grown in Penassay broth are shown in white bars [Panel A].
doi:10.1371/journal.pone.0004889.g001
E. coli O157:H7
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the gene chip data set. As described in the Materials and Method
section, a 2.0 log fold change and a p value of 0.05 were employed
as cut-off values. These statistical parameters identified 131 genes
(60 down-regulated and 71 up-regulated) that were differentially
regulated in EHEC due to growth in the presence of HEp-2 cells,
relative to the absence of epithelial cells Figure 2. (Individual
comparisons may be found in Supplemental Figure S2 and the
corresponding lists of genes can be found in Supplemental
Tables S1, S2 and S3).
Functional classification of differentially regulated genes
in EHEC O157:H7 grown in the presence or absence of
eukaryotic cells
Differentially regulated genes were categorized using a previ-
ously described functional classification system [21,26]. As shown
in Figure 3 [27], the majority of the gene changes were clustered
in the functional group comprising genes which encode for
transport and binding proteins (8.4%), energy metabolism factors
(11.5%), central intermediary metabolism factors (6.9%), and
factors involved in cellular processes (10.7%). The next set of
functional groups displaying the greatest gene expression changes
in relation to EHEC O157:H7 growth conditions were those
encoding macromolecule biosynthesis (amino acid biosynthesis:
3.5%; biosynthesis of cofactors: 0.8%; carbon compound biosyn-
thesis: 3.1%), cell structure components (3.8%), regulatory
components (0.8%), and putative factors (0.8–11.5%). As in most
microarrays, hypothetical proteins or genes of unknown function
accounted for the greatest percentage (23.7%) of all differentially
regulated genes in each comparison.
Hierarchical clustering of EHEC O157:H7 up-regulated
genes in response to growth in the presence of epithelial
cells
Cluster analysis was subsequently performed to identify the
relative expression pattern of up-regulated genes for EHEC
O157:H7 grown in the presence of epithelial cells, compared with
the pathogen grown in the absence of host epithelia. Hierarchical
clustering was employed to reveal degrees of similarity in the gene
expression profiles for the 71 up-regulated genes in EHEC
O157:H7 grown in the presence of HEp-2 cells, relative to
pathogen growth in the absence of eukaryotic cells. As shown in
Figure 4, Panel A, up-regulated genes were grouped into four
major clusters: labeled A–D. Genes in clusters A–D are listed in
Table 1. Genes in Cluster A primarily encode metabolism factors
and enzymes. In Cluster B, multiple genes coding for the E. coli
type three secretion system apparatus (i.e. escT, escS, escU, and escR)
were up-regulated. In cluster C, genes responsible for lipopoly-
saccharide biosynthesis (i.e. wbdP, wzx, and wbdO) were up-
regulated. In addition, in Cluster C, a lipoprotein (rlpB), a
prolipoprotein signal peptidase (lspA), and a putative receptor
(Z1178) were highly up-regulated as a result of pathogen growth in
the presence of epithelial cells. Cluster D contained several
transport factors (i.e. chuA, chuS, and chuT).
Gene Z1787: a novel putative virulence factor involved in
EHEC O157:H7 disruption of IFNc-Jak1,2-STAT-1 signaling
To confirm the microarray data, qRT-PCR was performed. As
shown in Figure 4, Panel B, transcript expression of gene Z1787
was significantly greater following EHEC growth in the presence
of epithelial cells than when the bacterium was grown in the
absence of epithelial cells (n=3; ANOVA, p,0.001).
Subsequently, isogenic knock-out mutants were generated by
employing the Lambda Red technique for gene deletion, as
previously described [28,29]. Gene Z1787 was selected as a
candidate virulence factor to be investigated via mutational
analysis due to its location on genomic island OI-50, a
.100 kbp genomic island. Gene knock-outs were verified using
reverse transcriptase polymerase chain reaction (RT-PCR). As
shown in Figure 5, transcript expression for EHEC gene Z1787
was positive in strain CL56 and parent strain EDL933, but absent
in both the knock-out, DZ1787 and in EPEC strain E2348/69.
Phenotypic analysis of the isogenic mutants was performed by
employing an in vitro tissue culture infection model followed by
immunoblotting. As shown in Figure 6, Panel A, unlike the
parent strain, EHEC strain EDL933, DZ1787 did not block
STAT-1 tyrosine phosphorylation in response to IFNc stimula-
tion. Quantification of immunoblots (Figure 6, Panel B)
demonstrate significantly greater STAT-1 tyrosine phosphoryla-
tion levels in epithelial cells infected with DZ1787
(119.13628.76% of uninfected control, n=4), relative to the
wild-type parent strain, EHEC strain EDL 933 (4.7065.19% of
uninfected control, n=4). Consistent with previous observations
[20], EHEC strain CL56 (1.50614.98%, n=4), but not EPEC
O127:H6 strain 2348/69 (98.0063.91%, n=4), inhibited tyrosine
phosphorylation of STAT-1 following IFNc stimulation. However,
complementation of the EHEC gene Z1787 knock out only
partially restored pathogen inhibition of STAT-1 tyrosine
phosphorylation (Figure 6, Panel B). Similarly, insertion of
gene Z1787 on a pGEM-T vector into non-pathogenic E. coli
strain HB101, did not result in the commensal being able to
completely subvert STAT-1 tyrosine phosphorylation by IFNc.I n
addition, transcript expression of Z1787 was not altered following
EHEC growth in the presence of a polarized intestinal epithelial
Figure 2. Volcano plot showing differential expression of EHEC
O157:H7, strain CL56 genes during bacterial growth in the
presence of epithelial cells, relative to the absence of epithelial
cells. Data points were extracted from a 1-way analysis of variance
(ANOVA): Gene expression changes during EHEC growth in the
presence of cultured epithelial cells, relative to pathogen growth in
the absence of epithelial cells. The x-axis represents ‘log fold change’
and the corresponding dark vertical lines represent cut-offs at log2.0-
fold decreases and increases. The y-axis represents p-values and the
corresponding dark horizontal lines indicate a p value cut-off of 0.05.
Values presented represent the number of down- and up-regulated
genes, respectively.
doi:10.1371/journal.pone.0004889.g002
E. coli O157:H7
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epithelial cells (Supplemental Figure S3). Collectively, these
data indicate that gene Z1787 is not the only factor mediating
EHEC subversion of STAT-1 activation. Instead, as for many
other microbial pathogens, multiple factors likely contribute to
pathogen subversion of immune signaling.
Discussion
This is the first study to characterize gene expression changes of
EHEC O157:H7 grown in the presence of epithelial cells,
compared to bacteria cultured in either minimal essential tissue
culture medium (in the presence and absence of 5% CO2)o r
Penassay broth alone. The Affymterix E. coli 2.0 gene chip
employed also was used by Hancock et al. [21] in their assessment
of uropathogenic E. coli gene expression changes in biofilm growth
versus planktonic conditions. An advantage of using this platform
is that it contains the complete genomes of both pathogenic and
non-pathogenic E. coli, thereby allowing for comparative studies
and an extensive evaluation of expression patterns in both
housekeeping genes and putative virulence factors. In our analyses,
relative expression of housekeeping genes remained consistent,
irrespective of EHEC growth conditions. By contrast, there was
up-regulation in a number of virulence genes in response to
exposure of the microbial pathogen to host epithelia. A putative
protease, Z1787, encoded on OI (O-island)-50 [9], was identified
Figure 3. Functional classification of the 131 differentially regulated genes during EHEC O157:H7 growth in the presence of
epithelial cells, relative to the absence of epithelial cells, as summarized in a pie chart [27]. Each pie slice represents a major functional
group of genes. Numbers shown represent percentage.
doi:10.1371/journal.pone.0004889.g003
E. coli O157:H7
PLoS ONE | www.plosone.org 4 March 2009 | Volume 4 | Issue 3 | e4889Figure 4. Hierarchical cluster plot showing relative expression patterns of EHEC O157:H7 up-regulated genes in the presence of
epithelial cells, relative to the absence of epithelial cells [Panel A]. Horizontal rows represent distinct genes and vertical columns represent
individual samples of EHEC O157:H7 grown in the presence of epithelial cells [(+) HEp-2], relative to the absence of epithelial cells [(2) HEp-2].
Relative expression patterns of EHEC O157:H7, strain CL56 gene Z1787 [Panel B]. qRT-PCR of Z1787 showing differences in transcript expression for
EHEC O157:H7 under varying growth condition. Data points are derived from triplicates of EHEC O157:H7 grown in epithelial cells versus microbial
growth in minimal essential medium (2/+5% CO2) were extrapolated from a standard curve generated for each primer pair using EHEC O157:H7
grown in Penassay broth. Data analysis was performed using the 7500 Sequence Detection System Software package (Applied Biosystems). Black
bars represent EHEC O157: H7 grown in the presence of HEp-2 cells; grey bars represent the pathogen grown in minimal essential medium in room
air; stripped bars represent microbial growth in minimal essential medium in 5% CO2.
doi:10.1371/journal.pone.0004889.g004
E. coli O157:H7
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Probeset ID: Gene Gene product / functional description Fold change
Cluster A: 8 up
1767702_s_at ilvC ketol-acid reductoisomerase 4.8518
1761586_s_at leuB 3-isopropylmalate dehydrogenase 3.3419
1768228_s_at actP acetate permease 2.6979
1767691_s_at gltB glutamate synthase, large subunit 2.6953
1764907_s_at betB NAD+-dependent betaine aldehyde dehydrogenase 2.3903
1767859_s_at ordL probable oxidoreductase 2.3018
Cluster B: 21 up
1761408_s_at entD enterobactin synthetase component D 6.1178
1762165_s_at bioC biotin biosynthesis; reaction prior to pimeloyl CoA 4.7654
1766687_s_at Z4919 putative ATP-binding protein of ABC transport system 3.6493
1763215_s_at bioD dethiobiotin synthetase 3.0056
1767427_s_at Z4853 putative acyl carrier protein 2.5431
1764491_s_at escT escT 2.4659
1765592_s_at urge putative urease accessory protein G 2.4320
1759270_s_at gltD glutamate synthase, small subunit 2.4262
1769074_s_at fepC ATP-binding component of ferric enterobactin transport 2.4050
1761897_s_at Z4854 putative acyl carrier protein 2.2304
1767820_s_at dniR transcriptional regulator for nitrite reductase 2.2142
1763082_s_at dppD putative ATP-binding component 2.1920
1763133_s_at escS escS 2.1702
1767609_s_at escU escU 2.1476
1767451_s_at gnd gluconate-6-phosphate dehydrogenase, decarboxylating 2.1268
1764551_s_at ureF putative urease accessory protein F 2.1104
1762528_s_at escR escR 2.0480
1760850_s_at waaY putative LPS biosynthesis protein 2.0172
Cluster C: 25 up
1759518_s_at exbB uptake of enterochelin 2.1552
1760472_s_at Z1341 unknown protein encoded by prophage CP-933M 2.5132
1760730_s_at chuU putative permease of iron compound ABC transport 3.8076
1760999_s_at wbdP glycosyl transferase 2.7773
1761010_s_at beta choline dehydrogenase, a flavoprotein 3.3830
1761172_s_at terE putative phage inhibition, colicin resis & tellurite resis. 2.5218
1761302_s_at terC putative phage inhibition, colicin resis & tellurite resis 3.4412
1762953_s_at wzx O antigen flippase Wzx 2.1944
1763001_s_at terE putative phage inhibition, colicin resis & tellurite resis 3.2745
1764750_s_at rlpB A minor lipoprotein 2.2008
1764929_s_at nuoG NADH dehydrogenase I chain G 2.3666
1765359_s_at chuW putative oxygen independent coproporphyrinogen III oxidase 4.9399
1765620_s_at glyA serine hydroxymethyltransferase 2.0473
1765959_s_at lspA prolipoprotein signal peptidase (SPase II) 2.3639
1766483_s_at Z1178 putative receptor 4.5374
1766799_s_at yafH putative acyl-CoA dehydrogenase (EC 1.3.99.-) 2.5048
1766809_s_at Z2778 putative aldehyde dehydrogenase 2.0451
1766905_s_at terA putative phage inhibition, colicin resis & tellurite resis 2.8857
1767319_s_at acrB acridine efflux pump 2.3176
1767505_s_at entE 2,3-dihydroxybenzoate-AMP ligase 3.7641
1767555_s_at Z1787 unknown protein encoded by prophage CP-933N 2.6642
1768558_s_at wbdO glycosyl transferase 2.7212
E. coli O157:H7
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subversion of IFNc- Jak1,2-STAT-1 signaling.
Relatively few studies have evaluated gene expression changes
of EHEC O157:H7 in the context of an infection model. EHEC
disease pathogenesis is initiated following pathogen contact with
host epithelial cells, and subsequently results in microbial
adhesion, toxin production, and modulation of host cell signal
transduction cascades [3,4]. Using microarrays, a previous study
described differential gene expression profiles of EHEC O157:H7
in response to bacterial growth in the presence of erythrocytes
[22]. Down-regulation of 299 genes and up-regulation of 105
genes was reported following EHEC growth in the presence of
rabbit erythrocytes, compared to culture of bacteria in minimal
essential tissue culture medium alone [22]. Dahan et al. (2004)
limited their study to gene expression changes of regulators and
factors encoded by the locus of enterocyte effacement (LEE)
pathogenicity island [30]. Common LEE encoded genes differen-
tially regulated following exposure of EHEC to either erythrocytes
or host epithelia include: escR, escS, escT, and escU. These results
demonstrate reproducibility both within and between microarray
studies. However, EHEC exposure to erythrocytes is not part of
the infectious process, whereas EHEC exposure to epithelial cells
lining the gut represents an early stage in disease pathogenesis [2].
Other studies employing microarray technology have evaluated
gene expression profiling of E. coli in the context of phylogenetic
studies [11–14,31] and in response to either different environ-
mental growth conditions or varying growth media [15–20]. For
instance, one previous study assessed the effects of minimal glucose
medium on uropathogenic E. coli gene expression, showing that
119 genes (2.8% of the genome) were up-regulated during
pathogen growth in enriched medium, relative to the minimal
glucose medium [32]. Two studies reported differential gene
expression changes of urinary tract E. coli isolates during growth in
biofilms, relative to planktonic growth [21,26].
Previous studies characterizing gene expression changes for
other enteric pathogens (Salmonella [33], Shigella [34], and Listeria
monocytogenes [35]) identified virulence factors mediating microbial
pathogenesis. These studies describe gene expression profiles of
such pathogens as distinctly different during intracellular growth,
relative to extracellular growth of the organism [33,36]. Subse-
quent studies demonstrated genes encoding the expression of
regulatory proteins and toxins during intracellular growth of the
pathogens [37]. Such studies demonstrate that characterization of
gene expression, by using microarray technology, can lead to a
detailed description of pathogenic factors involved in disease
progression [37].
Figure 5. Transcript expression of EHEC O157:H7 gene Z1787
in wild-type and mutant strains. As described in the Experimental
procedures, gene deletion was performed using the Lambda Red
technique [27–28]. Isogenic mutants were then screened and verified
using reverse transcriptase polymerase chain reaction (RT-PCR). PCR
products were electrophoresed on 2% agarose gel, stained with
ethidium bromide, and bands then visualized under a UV lamp. The
standard employed was a 100 bp ladder. Lane 1: negative water
control; Lane 2: EHEC strain CL56; Lane 3: EPEC strain E2348/69; Lane
4: EHEC strain EDL 933 (parent to the mutant); Lane 5: DZ1787; Lane
6: no transcript control. [Panel A] transcript expression of EHEC gene
Z1787; [Panel B] transcript expression of EHEC gapA. Primers are
described in Table 2 of the Materials and Methods.
doi:10.1371/journal.pone.0004889.g005
Probeset ID: Gene Gene product / functional description Fold change
Cluster D: 17 up
1762260_s_at chuA outer membrane hemehemoglobin receptor 6.0326
1763313_s_at chuS putative hemehemoglobin transport protein 5.5553
1768770_s_at chuT putative periplasmic binding protein 3.4813
1763337_s_at entF ATP-dependent serine activating enzyme 3.2049
1760675_s_at per perosamine synthetase 2.7632
1764806_s_at wbdQ GDP-mannose mannosylhydrolase 2.6713
1766849_s_at wzy O antigen polymerase 2.5446
1766583_s_at aceF pyruvate dehydrogenase 2.5072
1759808_s_at fadB 4-enzyme protein 2.4949
1761631_s_at terD putative phage inhibition, colicin resis & tellurite resis 2.4640
1759686_s_at fcI fucose synthetase 2.4502
1766456_s_at Z3198 GDP-mannose dehydratase 2.2236
1764835_s_at Z5136 Hypothetical protein / unknown function 2.1700
1759443_s_at manC mannose-1-P guanosyltransferase 2.1422
1764320_s_at gltA citrate synthase 2.0958
doi:10.1371/journal.pone.0004889.t001
Table 1. cont.
E. coli O157:H7
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50 in EHEC O157:H7 [7]. This bacterial protease may be
released from EHEC during pathogen infection. Subsequent
interactions of the protease with host epithelia could then
contribute to EHEC subversion of STAT-1 tyrosine phosphory-
lation. Bacterial proteases facilitate pathogen infection by direct
host tissue damage, by modulation of host cell signaling and by
processing of other bacterial virulence factors [38]. For instance,
the bacterial protease StcE, also encoded by EHEC O157:H7,
mediates bacterial adhesion [39] and displays proteolytic activity
against both intestinal mucins and C1 esterase inhibitor [40]. StcE
is insensitive to trypsin, chymotrypsin, and neutrophil elastase
[40]. Another EHEC protease, EspP, is a serine protease that is
cleaved and released into the extracellular environment during
bacterial infection [41], which then potentially can destroy host
cell surface receptors.
Bacterial proteases of other pathogens are also known to
modulate signaling cascades and act as virulence factors. For
instance, ScpC, a protease elaborated by Streptococcus pyogenes
displays immune modulation during pathogen infection. During
murine infection, ScpC degrades interleukin (IL)-8 and prevents
neutrophil transmigration and activation. Multiple proteases of
Pseudomonas aeruginosa (AprA, LasA, LasB, and protease IV) also are
involved in disease pathogenesis. AprA, in particular, targets
proteins of the complement system [42] and degrades pro-
inflammatory cytokines [43]. LepA is another protease of P.
aeruginosa that subverts NFkB activity by proteolytic activation of
eukaryotic cell protease-activated receptors (PARs) [44]. Serralysin
of Serratia marcescens is a protease that induces IL-6 and IL-8
expression in lung carcinoma cells. In addition, this protease
activates NFkB via PAR-2 activation [45]. Taken together, these
studies demonstrate that modulation (both activation and
inhibition) of multiple host signal transduction cascades occurs in
response to multiple bacterial proteases. Innate immune subver-
sion can be mediated by bacterial proteolytic degradation of
signaling molecules and their cognate receptors.
Gene expression analysis also should be validated using internal
controls to represent consistent mRNA expression levels, regard-
less of bacterial growth conditions [24]. An evolutionary and
phylogenetic analysis was previously used to identify seven
housekeeping genes (aroE, arcA, icd, mdh, mltD, pgi, and rpoS)i nE.
coli O157:H7 [25]. Among 21 EHEC isolates tested, these seven
housekeeping genes displayed ,8% variation at both the
nucleotide and amino acid levels [25]. Multi-locus sequence
typing of another set of seven housekeeping genes (arcA, dnaE, mdh,
gnd, gapA, and pgm) showed phylogenetic relatedness among EHEC
O157:H7 isolates [46]. The rfb-gnd gene cluster also has been
employed in evolutionary studies of EHEC O157:H7 [47].
However, EHEC O157:H7 housekeeping genes were not assessed
in previous microarray studies. The results of the current study
showed similar levels for both microarray signal intensities and
transcript expression of the five housekeeping genes tested (arcA,
gapA, mdh, rfbA, and rpoS) following EHEC growth in the presence
and absence of epithelial cells.
In summary, this study is the first to report global gene
expression changes following EHEC O157:H7 growth in the
presence and absence of host epithelia. We demonstrate increased
gene expression of multiple potential EHEC virulence factors
during bacterial growth in the presence of HEp-2 cells. Future
studies need to be undertaken to better define the virulence
potential and precise role of each of these genes in EHEC
O157:H7 disease pathogenesis.
Materials and Methods
Tissue culture
HEp-2 epithelial cells (American Type Culture Collection,
M a n a s s a s ,V A )w e r ee m p l o y e da sam o d e le p i t h e l i a lc e l ll i n e[ 4 ] .
Figure 6. EHEC O157:H7 gene Z1787 is a virulence factor
responsible for inhibition of STAT-1 tyrosine phosphorylation.
Cultured epithelial cells were infected with wild-type EHEC O157:H7,
strains CL56 and strain EDL 933, EHEC DZ1787 (in strain EDL 933) and
EPEC O127:H6 (MOI 100:1) for 6 hr (or as described in the Experimental
procedures)a t3 7 uCi n5 %C O 2. Washed cells were then stimulated with
interferon (IFN)-c (50 ng/mL) for 0.5 hr at 37uCi n5 %C O 2. Whole cell
protein extracts were collected and immunoblots probed with either
anti-latent-STAT-1 or anti-phospho-STAT-1 and anti-b-actin primary
antibodies, followed by respective secondary antibodies. [Panel A]
Positively staining bands were detected by using an infrared scanner.
Lanes 1 & 2: uninfected epithelial cells in the absence and presence of
interferon-c, respectively; Lane 3: EHEC O157:H7, strain CL56 inhibited
STAT-1 tyrosine phosphorylation; Lanes 4: EPEC did not disrupt STAT-1
tyrosine phosphorylation. Lane 5: Wild-type EHEC O157:H7, strain
EDL933 inhibited IFNc stimulated STAT-1 activation. Lane 6: Gene
disruption of Z1787 in EDL 933 prevented EHEC subversion of STAT-1
signaling in response to IFNc. [Panel B] Densitometry of positively
stained bands was quantified using software imbedded in the infrared
scanner. Quantification of STAT-1 tyrosine phosphorylation in epithelial
cells infected with EHEC O157:H7 complemented with gene Z1787
using the pGEM-T vector also was determined. As a positive control,
levels of STAT-1 tyrosine phosphorylation also were determined in
epithelial cells treated with non-pathogenic E. coli strain HB101: wild-
type bacteria did not inhibit STAT-1 activation, while HB101+gene
Z1787 (inserted on the pGEM-T vector) resulted in partially reduced
levels of STAT-1 tyrosine phosphorylation (n=1–4; ANOVA, *p,0.01).
doi:10.1371/journal.pone.0004889.g006
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containing 15% (v/v) fetal bovine serum, 2% (v/v) sodium
bicarbonate, 2.5% (v/v) penicillin streptomycin, and 1% (v/v)
fungizone (all from Invitrogen, Burlington, ON. Canada) [7]. Cells
were grown in T25 flasks (Corning Incorporated, Corning, NY) at
37uCi n5 %C O 2 until confluent (2–3610
6). Confluent cells were
trypsinized using 0.05% trypsin for 20 min at 37uCi n5 %C O 2.
Trypsinized cells were then pelleted, centrifuged at 500 rpm for
5 min (Beckman Coulter, Mississauga, Ontario), resuspended in
minimal essential tissue culture medium, and re-seeded into either
T25 flasks or 6-cm Petri dishes (Becton Dickinson Labware, Franklin
Lakes, NJ) and againgrown at 37uCi n5 %C O 2until confluent. Prior
to bacterial infection, cells were incubated (24 hr at 37uCi n5 %C O 2)
in minimal essential tissue culture medium without antibiotics and
fetal bovine serum, as previously described [5].
A polarized intestinal epithelial cell line, T84, was employed as
a complementary cell line for PCR experiments. As previously
described [6], T84 cells were grown in a 1:1 mixture of Dulbecco’s
modified Eagle’s medium and Ham’s F-12 medium. Culture
medium was supplemented with 10% (vol/vol) fetal bovine serum
(FBS), 2% penicillin-streptomycin, 2% sodium bicarbonate, and
0.6% L-glutamine (all obtained from Life Technologies, Grand
Island, NY). Cells were grown to confluence and trypzinized with
0.25% trypsin.
Bacterial strains and growth conditions
Bacterial strains used in this study included, enterohemorrhagic
E. coli (EHEC), strains CL56 and EDL 933 (serotype O157:H7)
and enteropathogenic E. coli (EPEC) strain E2348/69 (serotype
O127:H6). EHEC strain CL56, originally isolated from a child
with hemorrhagic colitis and hemolytic-uremic syndrome at the
Hospital for Sick Children in Toronto, Canada is routinely used in
our laboratory as a model EHEC strain [5–7]. The eae-positive
EPEC strain E2348/69 was used for comparative purposes.
Bacteria were grown, as previously described [5–7]. Briefly, strains
were grown on 5% sheep blood agar plates (Becton, Dickinson and
Company, Sparks, MD) at 37uC for 24 hr. Prior to infecting
epithelial cells, bacteria were grown in 10 mL Penassay broth
(Becton, Dickinson Co.) overnight at 37uC. For RNA extraction,
overnight culture (1610
9 CFU per mL) of EHEC O157:H7 was
used to inoculate 10 mL of sterile Penassay broth (6 hr re-growth
in 37uC), and 10 mL of minimal essential medium (6 hr re-growth
in 37uC) incubated in either room air or 5% CO2 (6 hr re-growth
in 37uC).
Epithelial cell infection
EHEC O157:H7 infection of HEp-2 or T84 epithelial cells was
performed at a multiplicity of infection (MOI) of 100:1 [6]. Briefly,
0.8 mL of an overnight bacterial culture was centrifuged at
3,000 rpm for 5 min, supernatants decanted, and bacterial pellets
resuspended in 0.1 mL of Minimal Essential Medium. An aliquot
of this bacterial resuspension (2610
8 CFU in 0.025 mL) was used
to infect confluent epithelial cells grown in 6 cm Petri dishes. HEp-
2 or T84 cells were infected with EHEC O157:H7 for 6 hr at
37uCi n5 %C O 2. At the end of the 6 hr infection period, both
adherent and non-adherent EHEC O157:H7 cells were collected
for total RNA extracts. For some experiments, at end of the 6 hr
infection period, cells were washed and then stimulated with IFNc
(50 ng/mL for 0.5 hr at 37uCi n5 %C O 2), followed by whole cell
protein extracts for immunoblotting.
RNA extraction
RNA extracts of EHEC O157:H7 from each of the four growth
conditions were prepared using the Qiagen RNeasy mini-prep kit
(Qiagen, Mississauga, Ontario, Canada). A total of 19 RNA
extracts (that is, 4 or 5 gene chips for each of the four growth
conditions) were prepared. Briefly, bacteria were harvested at
5,000 rpm for 5 min at 4uC. Bacterial pellets were re-suspended in
0.1 mL Tris-EDTA buffer (pH 7.6; Fisher Scientific, Ottawa,
Ontario, Canada) containing 0.04 mg Lysozyme (Pierce, Rock-
ford, IL) at room temperature for 3–5 min. Subsequently,
0.350 mL of lysis buffer (RLT buffer; Qiagen) containing 1% b-
mercaptoethanol (Kodak) was added and bacterial re-suspensions
vortexed vigorously. The entire sample was then loaded into a
mini spin column (QIA shredder; Qiagen) and centrifuged in a
mini-centrifuge (Beckman Coulter, Mississauga, Ontario, Canada)
for 2 min. Supernatants were collected, washed with 0.25 mL of
100% ethanol, and loaded into a silica membrane mini-column
(RNeasy mini column; Qiagen). Samples were again centrifuged at
10,000 rpm for 15 sec, flow throughs discarded, and 0.350 mL of
wash buffer (RWI buffer; Qiagen) added to each mini-column.
Ethanol-containing wash buffer (RPE buffer; Qiagen) was then
loaded into each mini-column and centrifuged at 10,000 rpm for
1 min. Purified RNA was collected off the silica membrane using
0.025 mL of RNase free water (Qiagen) and centrifugation at
10,000 rpm for 1 min. DNA was removed by adding 0.80 mL
(27.3 Kunitz units) DNase in DNA digest buffer (Qiagen) for
15 min at room temperature.
RNA concentration and purity
Purified RNA was diluted (1/10) in DEPC-treated water
(Fischer Scientific) and OD 260/280 readings were obtained
using a spectrophotometer (Ultrospec 2100 Pro UV–VIS spectro-
photometer; Biochrom, Cambridge, England). Samples with an
OD 260/280 ratio of 1.8 or greater and a minimum concentration
of 0.5 mg/mL were used for subsequent analyses. RNA quality
was determined on a 1% agarose gel (Sigma Aldrich). One mgo f
each RNA sample was combined with loading buffer, and gels
subject to electrophoresis at 80 V for 40–50 min at room
temperature. As a standard, a high DNA mass ladder (Invitrogen)
was added to the first lane of the agarose gel. RNA bands were
visualized under an ultraviolet lamp.
Microarray
For microarray analysis, high quality RNA was sent to a
microarray facility (The Centre for Applied Genomics, Hospital for
Sick Children, Toronto, Ontario, Canada). An independent
internal RNA quality control was performed using the Agilent
2100 bioanalyzer (Aqilent Technologies Inc., Santa Clara, CA).
Subsequently, RNA extracts were processed for microarray
analysis, as previously described [21]. Detailed protocols describing
labeling, hybridization, image acquisition, and normalization can
be obtained from: www.affymetrix.com. The E. coli Genome 2.0
gene chip (Affymetrix, Santa Clara, CA), which contains the
complete genomes of four E. coli strains (non-pathogenic E. coli K12,
strain MG1655, uropathogenic E. coli, strain CFT073, and
enterohemorrhagic E. coli O157:H7, strains EDL 933 and Sakai)
was employed. The gene chip consists of 10,000 probe sets for all
20,366 genes of the four bacteria. The number of probe sets unique
to EDL 933 O157:H7 include: 5,480 while the number of EDL 933
O157:H7-specific transcripts is 5,376 (www.affymetrix.com).
Microarray data analyses
Data analyses from 19 gene chips were performed using the
Partek Genomics Suite version 6.08.0128 (Partek Inc., St Louis,
MO) (GEO Accession# GSE14238). Affymetrix .cel files were
imported into Partek with the Robust Multichip Average
algorithm (RMA; [48]) feature ‘on’ in order to normalize data
E. coli O157:H7
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background correction, quantile normalization across gene chips,
log base 2 transformation, and median polish summarization.
Data were filtered to include only EHEC O157:H7 strains EDL
933 and Sakai specific genes. The Partek workflow was set to
‘Gene Expression’ for subsequent data analyses.
Statistics
One-way analysis of variance (ANOVA) was performed to
identify genes altered by at least a 2.0-fold increase or decrease in
expression between groups. The numbers of significantly up- and
down-regulated genes in each comparison group were identified
by applying a p value of ,0.05, together with fold change cut-offs
of 2.0-fold decrease and 2.0-fold increase [6,21–22].
cDNA synthesis
For PCR analysis, cDNA synthesis was performed using the
Invitrogen Thermoscript kit (Invitrogen). Briefly, 1 mgo fR N A
template was reverse transcribed using random hexamer primers in
buffered conditions (16 synthesis buffer; 0.1 M DTT, 40 U/ml
RNaseOUT
TM;1 5U / mlT h e r m o s c r i p t
TMRT). The reaction was
incubated for 50 min at 60uC and terminated at 85uCf o r5m i n .A t
the end of the cycle, 200 U RNase H (Invitrogen) was added to each
reaction tube and samples incubated at 37uC for 20 min and then
stored at 220uC.
Reverse Transcription PCR (RT-PCR)
The cDNA templates wereamplified using 0.2 mMofeachspecific
primer (Table 2), 0.2 mM dNTP, 25 mM MgCl2,1 . 2 5UTaq
polymerase (Fermentas, Burlington, Ontario, Canada) in supplied
b u f f e r( 1 0m MT r i s - H C l ,p H8 . 8 ;5 0m MK C l ,0 . 0 8 %N P 4 0 ) .T h e
reaction was incubated at 95uC for 10 min, followed by 45 cycles of
95uC (30 sec), 55uC (60 sec) and 72uC (30 sec). All products were
resolved ona 2%agarose gelin16TAE buffer and then stained with
ethidium bromide (50 mg/mL) for visualization of bands.
Quantitative real time polymerase chain reaction (qRT-
PCR)
Transcript expression of EHEC O157:H7 grown in the presence
or absence of epithelial cells were compared using gene-specific
primers. A series of 10-fold dilutions of cDNA was used to generate
a standard curve and a 1:50 dilution of sample cDNA quantified,
relative to this series. The qRT-PCR reactions were performed
using either the ABI 7900HT Real-Time PCR System (Applied
Biosystems) or the BioRad CFX96 (BioRad Laboratories, Hercules,
CA) and SYBR Green PCR Master Mix (Applied Biosystems), in
triplicate. Primers were obtained from IDT DNA (Integrated DNA
Technologies Inc., Coralville, IA) and constructed under HPLC
conditions. The qRT-PCR reactions were performed in a 20 ml
reaction with 0.2 mM primer. Template was pre-incubated at 50uC
for 2 min, denatured at 95uC for 10 min and subjected to 45 cycles
of the following thermal conditions: 95uC (15 sec) and 60uC
(60 sec). The product cycle threshold (CT) was determined from
ROX-normalized fluorescence emission and used to calculate the
initial input oftemplate.Allvaluesreported representthe meanofat
least three independent experiments.
Gene mutation
Isogenic mutants of EHEC O157:H7, strain EDL 933 were
constructed using the Lambda Red technique [28–29]. Plasmids
used for recombineering included pKD46 (AmpR; Red recombi-
nase expression plasmid) and pKD4 (template plasmid with FLP
recognition target sites flanking a kanamycin resistance gene).
Primers designed for the construction of PCR-generated DNA
fragments were: 59-CAA TCT TCA TCA TTA AAT AAA AGG
AGT GCT TAT GGT GTA GGC TGG AGC TGC TTC G-39
(forward primer) and 59-GTC TTA TAA ATT TAA AAC CAT
AGA AAA AAT CAA TTA TGA TAT GAA TAT CCT CCT
TA-39 (reverse primer). PCR products were generated by using
primers designed to include ends of the gene that was excised as
well as flanking regions of the gene. The extensions attached to
forward and reverse primers included, 39-GTG TAG GCT GGA
GCT GCT TCG-59 and 39- ATA TGA ATA TCC TCC TTA-
59, respectively. Plasmid DNA was extracted by using a Miniprep
Kit (Qiagen). Plasmid pKD4 was used as template for the primer
pair to amplify DNA fragments for recombination. PCR
amplicons were verified on a 1% agarose gel and subsequently
purified using a PCR Purification Kit (Qiagen).
EHEC O157:H7 strain EDL933 was transformed with pKD46
using a standard calcium chloride method. These transformants
containing the Red helper plasmid pKD46 were made electro-
competent by growing 30 ml cultures with ampicillin and L-
arabinose at 30uC on a shaker until mid-log phase when OD 600
reached 0.6. The cells were then pelleted by centrifugation at
8,000 rpm for 10 min at 4uC, washed 3 times with 25 mL ice cold
water, and resuspended in 100 mL ice cold water.
Purified PCR generated DNA was electroporated into electro-
competent EDL 933 transformants containing pKD46-AmpR.
Electroporation was performed using the Gene Pulser Xcell total
system (BioRad). Following electroporation, cells were recovered
using 1 mL Super Optimal Catabolite (Invitrogen) medium at
30uC for 3 hours. Mutants were then plated onto LB-Kan (25 mg/
mL) agar plates and grown overnight at 42uC. Colonies were
screened using PCR primers for the gene sequence of the target
gene to verify loss of the gene. New flanking junctions in the
mutants were also verified by PCR.
Complementation was performed as follows: PCR products
were amplified and purified, as described above. pGEM-T vector
ligation reactions were then performed using the pGEM-T kit
(Promega, Madison, WI) with 26buffer (5 mL), pGEM-T (1 mL),
PCR product (1.5 mL of 61.2 mg), and T4 DNA ligase (1 mL) up to
a volume of 10 mL. Reactions were left at 4uC for 24 hours.
Competent bacteria were generated, as described above, with
pelleted cells re-suspended using 10 mL ice-cold calcium chloride
(0.1 M). Re-suspended bacteria were incubated on ice for 10 min,
Table 2. Primers pairs used in this study for PCR.
Gene Primer Pairs Reference
arcA F: 59-GAA GAC GAG TTG GTA ACA CG-39 [25]; this study
R: 59-CTT CCA GAT CAC CGC AGA AGC-3
gapA F: 59-GAT TAC ATG GCA TAC ATG CTG-39 [49]; this study
R: 59-CAG ACG AAC GGT CAG GTC AA-39
mdh F: 59-CAA CTG CCT TCA GGT TCA GAA-39 [25]; this study
R: 59-GCG TTC TGG ATG CGT TTG GT-39
rfbA F: 59-GCG CTT TCG ACA TGT TGG ACA CTT-39 [50]; this study
R: 59-AAT TCC GTT CTT CCC TGG GTG CTA-39
rpoS F: 59-TAT GAG TCA GAA TAC GCT GAA A-39 [25]; this study
R: 59-GGA ACA GCG CTT CGA TAT TCA G-39
Z1787 F:59-ACT GTC ACT GTC AAC TCT CAG-39 this study
R:59-GGC AAC CAC TCA GGA AAA TG-39
doi:10.1371/journal.pone.0004889.t002
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decanted. Bacterial pellets were then resuspended to a final
volume of 50 mL in calcium chloride (0.1 M). Competent bacteria
were then transformed with the pGEM-T ligation products: 2 mL
of each ligation reaction was added to 50 mL of bacteria and
placed on ice for 30 min. Cells were then heat shocked for 2 min
in a water bath at 42uC. Immediately after, cells were returned to
an ice-water bath for 2 min. Bacteria transformed with the ligation
reaction were then recovered using 250 mL S.O.C. medium at
room temperature and incubated at 37uC for 1.5 hrs on a shaker.
Transformants were then plated onto LB/ampicillin/X-Gal
plates, which were incubated at 37uC overnight.
Whole cell protein extracts and immunoblotting
Whole cell protein extracts were conducted, as previously
described [5]. Briefly, cell extracts were centrifuged at 13,000 rpm
for 20 sec at 20uC, supernatants decanted and pellets re-suspended
in 0.150 mL RIPA buffer (1% Nonidet P-40, 0.5% sodium
deoxylate, 0.1% sodium dodecyl sulfate [SDS] in PBS) supple-
mented with 150 mM NaCl, 50 mM sodium fluoride, 1 mM
sodium ortho-vanadate, 20 mg/mL phenylmethylsulfonyl fluoride,
15 mg/mL aprotinin, 2 mg/mL leupeptin, and 2 mg/mL pepstatin
A (all from Sigma Aldrich, Oakville, Ontario, Canada), vortexed
well, and left on ice for 20 min. Re-suspended pellets were
centrifuged again at 12,000 rpm for 10 min at 4uC and superna-
tants stored at 280uC until further analysis by immunoblotting.
Immunoblotting was conducted, as previously described [5].
Whole cell protein extracts were combined with SDS-PAGE
loading buffer in a 2:1 (v/v) ratio, samples boiled for 3 min, and
then loaded into precast 10% polyacrylamide gels (Ready GelH;
BioRad Laboratories, Hercules, CA). Gels were electrophoresed at
150 V for 1 hr at room temperature followed by protein transfer
onto nitrocellulose membranes (BioTrace NT; Pall Corporation,
Ann Arbor, MI) at 110 V for 1.5–2 hr at 4uC.
Membranes were incubated in Odyssey blocking buffer
(LICOR Biosciences, Lincoln, NE) for 1 hr at 20uC on a shaker
followed by incubation with primary antibodies (4uC overnight on
a shaker). Primary antibodies included: anti-latent-STAT-1 (1 in
5,000 dilution; Santa Cruz Biotechnologies, Santa Cruz, CA),
anti-phospho-STAT-1 (1 in 1,000 dilution; Cell Signaling,
Beverly, MA), and anti-b-actin (1 in 5,000 dilution; Sigma).
Membranes were washed 4 times with PBS+ 0.1% Tween (5 min
per wash) and then incubated with secondary antibodies (1 hr at
4uC on a shaker). Secondary antibodies included: IRDye 800 goat
anti-rabbit IgG (1 in 20,000 dilution; Rockland Immunochemi-
cals, Gilbertsville, PA) and Alexa FluorH 680 goat anti-mouse IgG
(1 in 20,000 dilution; Molecular Probes, Eugene, OR) [5,6].
Immunoblots were scanned into an infrared imaging system
(Odyssey, LI-COR Biosciences), with both the 700 nm and
800 nm channels ‘on’ and immunoblots scanned at a resolution
of 169 mm [5]. Using automated software (LI-COR Biosciences)
densitometry was performed to obtain the integrative intensity of
all positively staining bands. Integrative intensity values for each of
the phospho-STAT-1 and latent-STAT-1 bands were normalized
to the integrative intensity values obtained for the corresponding
anti-b-actin bands. Uninfected cells stimulated with IFNc were
used as positive controls (standardized to 100%). Densitometry
values obtained from EHEC O157:H7 infected samples were then
calculated as a percentage of the positive, uninfected control [5].
Supporting Information
Figure S1 Principle component analysis (PCA) of microarray
chips: Seventeen separate samples generated a PCA value of
68.4%. Each point represents an array chip: circles represent
EHEC O157:H7, strain CL56 grown in the presence of HEp-2
cells; triangles represent bacteria grown in minimal essential
medium in 5% CO2; diamonds represents the pathogen grown in
minimal essential medium alone and squares represent organisms
grown in Penassay broth alone.
Found at: doi:10.1371/journal.pone.0004889.s001 (0.04 MB
PDF)
Figure S2 Volcano plots show differential expression of EHEC
O157:H7, strain CL56 genes under three individual growth
conditions. Data points were extracted from a 1-way analysis of
variance (ANOVA): [Panel A] Comparison of genes with altered
expression between EHEC grown in the presence of epithelial cells
versus bacteria grown in minimal essential medium in 5% CO2;
[Panel B] Bacterial growth in the presence of epithelial cells versus
bacterial growth in tissue culture medium in room air; [Panel C]
Pathogen growth in the presence of HEp-2 cells, compared with
growth in Penassay broth. . The x-axis represents ‘log fold change’
and the corresponding dark vertical lines represent cut-offs at log 2.0-
fold decreases and increases. The y-axis represents p-values and the
corresponding. Values presented represent the number of down- and
up-regulated genes, respectively. Top 20 up-regulated genes for each
panel are shown in Supplemental Tables S1, S2 and S3, respectively.
Found at: doi:10.1371/journal.pone.0004889.s002 (0.46 MB
PDF)
Figure S3 Relative expression patterns of EHEC O157:H7,
strain CL56 gene Z1787 and gapA, respectively. qRT-PCR of
Z1787 showing transcript expression for EHEC O157:H7 under
varying growth conditions. Data points are derived from triplicates
of EHEC O157:H7 grown in the presence or absence of polarized
epithelial cells, T84. Data analysis was performed using the
BioRad1.1CFXManager. Black bars represent EHEC O157: H7
grown in the presence of T84 cells; stripped bars represent the
pathogen grown in minimal essential medium in 5% CO2; grey
bars represent microbial growth in LB broth in 5% CO2; white
bars represent bacterial growth in LB broth in standard
conditions. Y-axis scale bar adjusted to be consistent with
Figure 4, Panel B.
Found at: doi:10.1371/journal.pone.0004889.s003 (0.03 MB
PDF)
Table S1
Found at: doi:10.1371/journal.pone.0004889.s004 (0.01 MB
DOC)
Table S2
Found at: doi:10.1371/journal.pone.0004889.s005 (0.01 MB
DOC)
Table S3
Found at: doi:10.1371/journal.pone.0004889.s006 (0.01 MB
DOC)
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